Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

DualityBio Enters $1 Billion Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs.

Aug 28, 2026•about 2 hours ago

Contract Type

agreement

ShanghaiBiotechnologyHealth CarePharmaceuticalBiopharma

Description

DualityBio has announced a global collaboration and license agreement with Genentech to develop next-generation antibody-drug conjugates utilizing their proprietary DUPAC platform. The agreement includes a $45 million upfront payment along with potential milestone payments exceeding $1 billion and tiered royalties on net sales.

Company Information

Company

DualityBio

Location

Shanghai, China

About

DualityBio is a biopharmaceutical company focused on drug development and clinical research. The company aims to deliver breakthrough therapies by leveraging international regulatory expertise and integrating clinical resources. They are committed to enhancing pipeline value and expanding globally. DualityBio is dedicated to next-generation ADC innovation.

Predictive Intelligence
Strategic

ML-powered predictions for DualityBio's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

DualityBio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.